Cargando…

Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic

Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Christopher J. L., Johnson, Ana P., Robinson, Danielle, Katyukha, Andriy, Egan, Rylan, Linton, Sophia, Parker, Christopher, Robinson, Andrew, Digby, Geneviève C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161784/
https://www.ncbi.nlm.nih.gov/pubmed/33947127
http://dx.doi.org/10.3390/curroncol28030157
_version_ 1783700575182913536
author Stone, Christopher J. L.
Johnson, Ana P.
Robinson, Danielle
Katyukha, Andriy
Egan, Rylan
Linton, Sophia
Parker, Christopher
Robinson, Andrew
Digby, Geneviève C.
author_facet Stone, Christopher J. L.
Johnson, Ana P.
Robinson, Danielle
Katyukha, Andriy
Egan, Rylan
Linton, Sophia
Parker, Christopher
Robinson, Andrew
Digby, Geneviève C.
author_sort Stone, Christopher J. L.
collection PubMed
description Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on health resource utilization, patient and caregiver costs, and secondary patient benefits. Methods: We retrospectively analyzed patients in a rapid assessment clinic with a new LC diagnosis pre-MDC (September 2016–February 2017) and post-MDC implementation (February 2017–December 2018). Data are reported as means; unpaired t-tests and ANOVA were used to assess for significance. We also conducted a cost analysis. Resource utilization, out-of-pocket costs, procedure-related costs, and indirect costs were evaluated from the societal perspective and presented in 2019 Canadian dollars (CAD); multi-way worst/best case and threshold sensitivity analyses were conducted. Results: We reviewed 428 patients (78 traditional model, 350 MDC). Patients in the MDC model required significantly fewer oncology visits from LC diagnosis to first LC treatment (1.62 vs. 2.68, p < 0.001), which was significant for patients with stage 1, 3, and 4 disease. Compared with the traditional model, there was no change in mean biopsies/patient (1.32 traditional vs. 1.17 MDC, p = 0.18) or staging investigations/patient (2.24 traditional vs. 2.02 MDC, p = 0.20). Post-MDC, there was an increase in invasive mediastinal staging for patients with stage 2/3 LC (15.0% vs. 60.0%, p < 0.001). Over 22 months, MDC resulted in savings of CAD 48,389 including CAD 24,167 CAD in direct patient out-of-pocket expenses. For the threshold analyses, MDC was estimated to cost CAD 25,708 per quality-adjusted life year (QALY), considered to be below current willingness to pay thresholds (at CAD 80,000 per QALY). MDC also facilitated oncology assessment for 29 non-LC patients. Conclusions: An MDC led to a reduction in patient visits and direct patient and caregiver costs.
format Online
Article
Text
id pubmed-8161784
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81617842021-05-29 Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic Stone, Christopher J. L. Johnson, Ana P. Robinson, Danielle Katyukha, Andriy Egan, Rylan Linton, Sophia Parker, Christopher Robinson, Andrew Digby, Geneviève C. Curr Oncol Article Background: Lung cancer (LC) care is resource and cost intensive. We launched a Multidisciplinary LC Clinic (MDC), where patients with a new LC diagnosis received concurrent oncology consultation, resulting in improved time to LC assessment and treatment. Here, we evaluate the impact of MDC on health resource utilization, patient and caregiver costs, and secondary patient benefits. Methods: We retrospectively analyzed patients in a rapid assessment clinic with a new LC diagnosis pre-MDC (September 2016–February 2017) and post-MDC implementation (February 2017–December 2018). Data are reported as means; unpaired t-tests and ANOVA were used to assess for significance. We also conducted a cost analysis. Resource utilization, out-of-pocket costs, procedure-related costs, and indirect costs were evaluated from the societal perspective and presented in 2019 Canadian dollars (CAD); multi-way worst/best case and threshold sensitivity analyses were conducted. Results: We reviewed 428 patients (78 traditional model, 350 MDC). Patients in the MDC model required significantly fewer oncology visits from LC diagnosis to first LC treatment (1.62 vs. 2.68, p < 0.001), which was significant for patients with stage 1, 3, and 4 disease. Compared with the traditional model, there was no change in mean biopsies/patient (1.32 traditional vs. 1.17 MDC, p = 0.18) or staging investigations/patient (2.24 traditional vs. 2.02 MDC, p = 0.20). Post-MDC, there was an increase in invasive mediastinal staging for patients with stage 2/3 LC (15.0% vs. 60.0%, p < 0.001). Over 22 months, MDC resulted in savings of CAD 48,389 including CAD 24,167 CAD in direct patient out-of-pocket expenses. For the threshold analyses, MDC was estimated to cost CAD 25,708 per quality-adjusted life year (QALY), considered to be below current willingness to pay thresholds (at CAD 80,000 per QALY). MDC also facilitated oncology assessment for 29 non-LC patients. Conclusions: An MDC led to a reduction in patient visits and direct patient and caregiver costs. MDPI 2021-04-29 /pmc/articles/PMC8161784/ /pubmed/33947127 http://dx.doi.org/10.3390/curroncol28030157 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Stone, Christopher J. L.
Johnson, Ana P.
Robinson, Danielle
Katyukha, Andriy
Egan, Rylan
Linton, Sophia
Parker, Christopher
Robinson, Andrew
Digby, Geneviève C.
Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
title Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
title_full Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
title_fullStr Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
title_full_unstemmed Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
title_short Health Resource and Cost Savings Achieved in a Multidisciplinary Lung Cancer Clinic
title_sort health resource and cost savings achieved in a multidisciplinary lung cancer clinic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161784/
https://www.ncbi.nlm.nih.gov/pubmed/33947127
http://dx.doi.org/10.3390/curroncol28030157
work_keys_str_mv AT stonechristopherjl healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT johnsonanap healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT robinsondanielle healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT katyukhaandriy healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT eganrylan healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT lintonsophia healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT parkerchristopher healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT robinsonandrew healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic
AT digbygenevievec healthresourceandcostsavingsachievedinamultidisciplinarylungcancerclinic